date:Sep 14, 2012
ia's goal of developing a research oriented biotechnology industry, and is unsound policy, according to participants.
All participants agreed that the issuance of India's Guidelines on Similar Biologics is a step in the right direction. The guidelines recognise the scientific and regulatory complexities presented by the development and manufacture of biologic medicines. What follows next is industry collaboration in the implementation of these guidelines in a manner that continues to protect pa